Trial Profile
Safety and Efficacy of Rivaroxaban in Adolescents and Young Adults with Venous Thromboembolism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 27 May 2017 New trial record